 evaluation, 3) examine the specific role of route-specific factors such as pulmonary antibody in mediating nicotine vaccine efficacy, and 3) develop quantitative models which can be more generally used to study the contributions of the inhaled route and other smoke constituents to tobacco addiction and treatment medications development. Nicotine vaccines are an attractive initial candidate for
evaluation, 3) examine the specific role of route - specific factors such as pneumonic antibody in intercede nicotine vaccine efficacy, and 3) develop quantitative models which can be more by and large use to study the contributions of the inhaled road and early smoke constituents to tobacco addiction and treatment medications development. Nicotine vaccine are an attractive initial candidate for
 evwluation, 3) examine the sptcific role of rootw-specihic facfors sucf as pulmonary antibody in mxdiaring bicotine vaccine efficxcy, and 3) fevelop wuanuitative models wijch can be modc genzrelly used to stody the contsibutions of tve iuhaled route and other smoke constittents tp hobacco addictyon sgd tdvaument medications development. Nicktine veccines are an sttractive initial candidahe flr
evaluation, 3) examine the specific role of such pulmonary antibody mediating nicotine vaccine models can be more used to study contributions of the inhaled route and smoke constituents to tobacco addiction and treatment medications development. Nicotine vaccines are an initial candidate for
 evaluation, 3) examine the speciFic role of rOute-sPecIfiC fActoRs suCh as pulmonary aNTiboDy in mediating nicotine vAccinE eFFicaCY, aNd 3) devElop quaNTiTATivE mOdEls WhICh Can be MorE generaLly used to sTudY tHe contributiONs Of the inhalEd rOute and other SmoKe consTiTueNTs to tObaCco adDictioN And treAtment medIcATions dEVelopmeNT. niCotiNe vaccines are an atTRaCTive initial canDidate FoR
 evaluation, 3) examine th e specific  role  of  ro ut e-sp ecif ic factors suc h  aspulmonary antibody inmedia ti n g ni c ot ine v accinee ff i c acy ,an d 3 )d ev elopqua ntitati ve modelswhi ch  can be more ge nerally us edto study the  co ntribu ti ons of th e i nhale d rout e  and o ther smok ec onstit u ents to t ob acco  addiction and tr e at m ent medication s deve lo p me n t . N ico tine vacci ne s are an attr a ct i v e  in i tial candidat e for
 evaluation,_3) examine_the specific role of_route-specific factors_such_as pulmonary_antibody_in mediating nicotine_vaccine efficacy, and_3) develop quantitative models_which can be_more_generally used to study the contributions of the inhaled route and other smoke constituents_to_tobacco addiction_and_treatment_medications development. Nicotine vaccines are_an attractive initial candidate for